Safety and efficacy of endoscopic retrograde cholangiopancreatography for common bile duct stones in liver cirrhotic patients

De-min Li , Jie Zhao , Qiu Zhao , Hua Qin , Bo Wang , Rong-xiang Li , Min Zhang , Ji-fen Hu , Min Yang

Current Medical Science ›› 2014, Vol. 34 ›› Issue (4) : 612 -615.

PDF
Current Medical Science ›› 2014, Vol. 34 ›› Issue (4) : 612 -615. DOI: 10.1007/s11596-014-1325-x
Article

Safety and efficacy of endoscopic retrograde cholangiopancreatography for common bile duct stones in liver cirrhotic patients

Author information +
History +
PDF

Abstract

In order to investigate the safety and efficacy of endoscopic retrograde cholangiopancreatograpy (ERCP) in liver cirrhosis patients with common bile duct stones, we retrospectively analyzed data of 46 common bile duct stones patients with liver cirrhosis who underwent ERCP between 2000 and 2008. There were 12 cases of Child-Pugh A, 26 cases of Child-Pugh B, and 8 cases of Child-Pugh C. 100 common bile duct stones patients without liver cirrhosis were randomly selected. All the patients were subjected to ERCP for biliary stones extraction. The rates of bile duct clearance and complications were compared between cirrhotic and non-cirrhotic patients. The success rate of selective biliary cannulation was 95.6% in liver cirrhotic patients versus 97% in non-cirrhotic patients (P>0.05). The bile duct clearance rate was 87% in cirrhotic patients versus 96% in non-cirrhotic patients, but the difference was not statistically significant. Two liver cirrhotic patients (4.35%, 2/46) who were scored Child-Pugh C had hematemesis and melena 24 h after ERCP. The hemorrhage rate after ERCP in non-cirrhotic patients was 3%. The hemorrhage rate associated with ERCP in Child-Pugh C patients was significantly higher (25%, 2/8) than that (3%, 3/100) in non-cirrhotic patients (P<0.01%). There was no significant difference between these two groups in the rate of post-ERCP pancreatitis (PEP) and cholangitis. ERCP is safe and effective for Child-Pugh A and B cirrhotic patients with common bile duct stones. Hemorrhage risk in ERCP is higher in Child-Pugh C patients.

Keywords

liver cirrhosis / common bile duct stone / endoscopic retrograde cholangiopancreatography

Cite this article

Download citation ▾
De-min Li, Jie Zhao, Qiu Zhao, Hua Qin, Bo Wang, Rong-xiang Li, Min Zhang, Ji-fen Hu, Min Yang. Safety and efficacy of endoscopic retrograde cholangiopancreatography for common bile duct stones in liver cirrhotic patients. Current Medical Science, 2014, 34(4): 612-615 DOI:10.1007/s11596-014-1325-x

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

TanakaR, ItoshimaT, NagashimaH. Follow-up study of 582 liver cirrhosis patients for 26 years in Japan. Liver, 1987, 7(6): 316-324

[2]

Del OlmoJA, GarcíaF, SerraMA, et al.. Prevalence and incidence of gallstones in liver cirrhosis. Scand J Gastroenterol, 1997, 32(10): 1061-1065

[3]

AcaloversuschiM, BadeaR, PascuM. Incidence of gallstones in liver cirrhosis. Am J Gastroenterol, 1991, 86(9): 1179-1181

[4]

AcaloversuschiM, BadeaR, DumitraşcuD, et al.. Prevalence of gallstones in liver cirrhosis: a sonographic survey. Am J Gastroenterol, 1988, 83(9): 954-956

[5]

VanhuyseF, MaureiraP, PortocarreroE, et al.. Cardiac surgery in cirrhotic patients: results and evaluation of risk factors. Eur J Cardiothorac Surg, 2012, 42(2): 293-299

[6]

MansourA, WatsonW, ShayaniV, et al.. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery, 1997, 122(4): 730-736

[7]

O’LearyJG, YachimskiPS, FriedmanLS. Surgery in the patient with liver disease. Clin Liver Dis, 2009, 13(2): 211-231

[8]

FreitasML, BellRL, DuffyAJ. Choledocholithiasis: evolving standards for diagnosis and management. World J Gastroenterol, 2006, 12(20): 3162-3167

[9]

WilliamsEJ, GreenJ, BeckinghamI, et al.. Guidelines on the management of common bile duct stones (CBDS). Gut, 2008, 57(7): 1004-1021

[10]

ItoiT, WangHP. Endoscopic management of bile duct stones. Dig Endosc, 2010, 22(Suppl1): S69-75

[11]

BaronTH, HarewoodGC. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a meta analysis of randomized, controlled trials. Am J Gastroenterol, 2004, 99(8): 1455-1460

[12]

WatanabeH, YonedaM, TominagaK, et al.. Comparison between endoscopic papillary balloon dilatation and endoscopic sphincterotomy for the treatment of common bile duct stones. J Gastroenterol, 2007, 42(1): 56-62

[13]

TodaN, SaitoK, WadaR, et al.. Endoscopic sphincterotomy and papillary balloon dilation for bile duct stones. Hepatogastroenterology, 2005, 52(63): 700-704

[14]

ZhaoHC, HeL, ZhouDC, et al.. Meta-analysis comparison of endoscopic papillary balloon dilatation and endoscopic sphincteropapillotomy. World J Gastroenterol, 2013, 19(24): 3883-3891

[15]

PratF, TennenbaumR, PonsotP, et al.. Endoscopic sphincterotomy in patients with liver cirrhosis. Gastrointest Endosc, 1996, 43(2Pt1): 127-131

[16]

KawabeT, KomatsuY, TadaM, et al.. Endoscopic papillary balloon dilation in cirrhotic patients: removal of common bile duct stones without sphincterotomy. Endoscopy, 1996, 28(8): 694-698

[17]

ParkDH, KimMH, LeeSK, et al.. Endoscopic sphincterotomy versus endoscopic papillary balloon dilation for choledocholithiasis in patients with liver cirrhosis and coagulopathy. Gastrointest Endosc, 2004, 60(2): 180-185

[18]

ChildCG, TurcotteJG. Surgery and portal hypertension. Major Probl Clin Surg, 1964, 1: 1-85

[19]

KamathPS, WiesnerRH, MalinchocM, et al.. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33(2): 464-470

[20]

CottonPB, LehmanG, VennesJ, et al.. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc, 1991, 37(3): 383-393

[21]

FreemanML, NelsonDB, ShermanS, et al.. Complications of endoscopic biliary sphincterotomy. N Engl J Med, 1996, 335(13): 909-918

[22]

AndriulliA, LoperfidoS, NapolitanoG, et al.. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol, 2007, 102(8): 1781-1788

[23]

StaritzM, EweK, Meyer zum BüschenfeldeKH. Endoscopic papillary dilation (EPD) for the treatment of common bile duct stones and papillary stenosis. Endoscopy, 1983, 15(Suppl1): 197-198

[24]

MayGR, CottonPB, EdmundsSE, et al.. Removal of stones from the bile duct at ERCP without sphincterotomy. Gastrointest Endosc, 1993, 39(6): 749-754

[25]

Mac MathunaP, WhiteP, ClarkeE, et al.. Endoscopic sphincteroplasty: a novel and safe alternative to papillotomy in the management of bile duct stones. Gut, 1994, 35(1): 127-129

[26]

FreemanML. Adverse outcomes of ERCP. Gastrointest Endosc, 2002, 56(6Suppl): S273-S282

[27]

ASGE Standards of Practice CommitteeAndersonMA, FisherL, JainR, et al.. Complications of ERCP. Gastrointest Endosc, 2012, 75(3): 467-473

[28]

ThalheimerU, TriantosCK, SamonakisDN, et al.. Infection, coagulation, and variceal bleeding in cirrhosis. Gut, 2005, 54(4): 556-563

AI Summary AI Mindmap
PDF

113

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/